351210 <common-name>2-[[4-(4-chlorophenyl)-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide</common-name> <description>2-[[4-(4-chlorophenyl)-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide is a chemical compound with the formula C31H24ClN5O2S2. With an average molecular weight of 598.10 g/mol, 2-[[4-(4-chlorophenyl)-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide is a heavy molecule.</description> <cas>618880-62-9</cas> <pubchem-id>4597428</pubchem-id> <chemical-formula>C31H24ClN5O2S2</chemical-formula> <weight>598.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T16:46:59Z</created-at> <updated-at type="dateTime">2026-08-31T16:46:59Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CC2=C(C=C1)N=C(S2)C3=CC=C(C=C3)NC(=O)CSC4=NN=C(N4C5=CC=C(C=C5)Cl)C6=CC=C(C=C6)OC</moldb-smiles> <moldb-formula>C31H24ClN5O2S2</moldb-formula> <moldb-inchi>InChI=1S/C31H24ClN5O2S2/c1-19-3-16-26-27(17-19)41-30(34-26)21-4-10-23(11-5-21)33-28(38)18-40-31-36-35-29(20-6-14-25(39-2)15-7-20)37(31)24-12-8-22(32)9-13-24/h3-17H,18H2,1-2H3,(H,33,38)</moldb-inchi> <moldb-inchikey>HUSMUTUYBIWCJS-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">597.1059951</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM347103</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[4-(4-chlorophenyl)-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0301510</sync-id> <structure-inchikey>HUSMUTUYBIWCJS-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000200000800000000800000000002000000100000080005000000000000010000000200004008000002080000000000000000000000000200000000000000004400000000000000000000020000010000100000200000010000000040000010080010050000000100400840000000100000040020000000004000000000040020400004000000000200080880000010000000000000000000000000000000000000000000000080000000000000000410000000000002c00000080000000000000000000000000000000040010000000002000000220000000000000008140000001000040000000000400020004010000000040000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAApAAAALgAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEH QCgAAAADAwZAKAAAAAMEEEAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQZAaAAA AAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBwBoAAAAAwIBBgAoAAAA AwQIACgAAAADAgYAYAAAAAICEAAgAAAAAgZAKAAAAAMEB0AoAAAAAwMHQCgA AAADAwZAKAAAAAMEB0AoAAAAAwMGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMD AQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBEQAgAAAAAQZAKAAAAAMEBkBo AAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEIACgA AAADAgYAYAAAAAEDCwABAAECaAwCA2gMAwRoDAQFaAwFBmgMBAdoDAcIaAwI CWgMCAogCgtoDAsMaAwMDWgMDQ5oDA4PaAwNECAQESAREigCERMAExQAFBUA FRZoDBYXaAwXGGgMGBloDBkaIBobaAwbHGgMHB1oDB0eaAweH2gMHSAAGCEg ISJoDCIjaAwjJGgMJCVoDCUmaAwkJyAnKAAGAWgMCQNoDA8KaAwZFWgMHxpo DCYhaAxCBgAAAAYBBgUEAwIFBwQDCQgGCwwNDg8KBRYVGRgXBhscHR4fGgYi IyQlJiEXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:49:08Z</structure-indexed-at> </compound>